Curation
Ncbi
Racine
Curation
Checkpoint
Ncbi
Racine
Ncbi
Exploration
Accueil
Racine
Racine

Serveur d'exploration sur le lymphœdème

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Leg edema from intrathecal opiate infusions.

Identifieur interne : 000505 ( Ncbi/Curation ); précédent : 000504; suivant : 000506

Leg edema from intrathecal opiate infusions.

Auteurs : J A Aldrete [États-Unis] ; Couto da Silva JM

Source :

RBID : pubmed:11124008

Descripteurs français

English descriptors

Abstract

Despite the increasing popularity of intrathecal infusions to treat patients with long-term non-cancer-related pain, this therapy is not without serious side-effects. Five out of 23 patients who had intrathecal infusions of opiates for longer than 24 months developed leg and feet edema. As predisposing factors, cardiovascular disease, deep venous thrombosis, peripheral vascular disease, and venous stasis of the lower extremities were considered. Every patient who developed pedal and leg edema after the implantation of an infusion pump was also found to have leg edema and venous stasis prior to the time when the pump was inserted. This complication was severe enough to limit their physical activity, and to produce lymphedema, ulcerations and hyperpigmentation of the skin. Reduction of the edema occurred when the dose of the opiate was decreased, and in two cases in which the infusion was discontinued, there was almost complete resolution of the syndrome. It appears that the pre-existence of pedal edema and of venous stasis is a relative contraindication to the long-term intrathecal infusion of opiates in patients with chronic non-cancer pain.

DOI: 10.1053/eujp.2000.0199
PubMed: 11124008

Links toward previous steps (curation, corpus...)

Links to Exploration step

pubmed:11124008

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Leg edema from intrathecal opiate infusions.</title>
<author>
<name sortKey="Aldrete, J A" sort="Aldrete, J A" uniqKey="Aldrete J" first="J A" last="Aldrete">J A Aldrete</name>
<affiliation wicri:level="2">
<nlm:affiliation>Department of Anesthesiology, University of South Florida School of Medicine, Tampa, Florida, USA. taldrete@arachnoiditis.com</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Anesthesiology, University of South Florida School of Medicine, Tampa, Florida</wicri:regionArea>
<placeName>
<region type="state">Floride</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Couto Da Silva Jm" sort="Couto Da Silva Jm" uniqKey="Couto Da Silva Jm" last="Couto Da Silva Jm">Couto da Silva JM</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2000">2000</date>
<idno type="RBID">pubmed:11124008</idno>
<idno type="pmid">11124008</idno>
<idno type="doi">10.1053/eujp.2000.0199</idno>
<idno type="wicri:Area/PubMed/Corpus">004936</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">004936</idno>
<idno type="wicri:Area/PubMed/Curation">004936</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">004936</idno>
<idno type="wicri:Area/PubMed/Checkpoint">004936</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">004936</idno>
<idno type="wicri:Area/Ncbi/Merge">000505</idno>
<idno type="wicri:Area/Ncbi/Curation">000505</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Leg edema from intrathecal opiate infusions.</title>
<author>
<name sortKey="Aldrete, J A" sort="Aldrete, J A" uniqKey="Aldrete J" first="J A" last="Aldrete">J A Aldrete</name>
<affiliation wicri:level="2">
<nlm:affiliation>Department of Anesthesiology, University of South Florida School of Medicine, Tampa, Florida, USA. taldrete@arachnoiditis.com</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Anesthesiology, University of South Florida School of Medicine, Tampa, Florida</wicri:regionArea>
<placeName>
<region type="state">Floride</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Couto Da Silva Jm" sort="Couto Da Silva Jm" uniqKey="Couto Da Silva Jm" last="Couto Da Silva Jm">Couto da Silva JM</name>
</author>
</analytic>
<series>
<title level="j">European journal of pain (London, England)</title>
<idno type="ISSN">1090-3801</idno>
<imprint>
<date when="2000" type="published">2000</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Arachnoiditis (drug therapy)</term>
<term>Causality</term>
<term>Chronic Disease</term>
<term>Comorbidity</term>
<term>Edema (chemically induced)</term>
<term>Edema (diagnosis)</term>
<term>Edema (epidemiology)</term>
<term>Foot (pathology)</term>
<term>Hyperpigmentation (chemically induced)</term>
<term>Hyperpigmentation (diagnosis)</term>
<term>Hyperpigmentation (epidemiology)</term>
<term>Incidence</term>
<term>Infusion Pumps, Implantable</term>
<term>Injections, Spinal</term>
<term>Leg (pathology)</term>
<term>Lymphedema (diagnosis)</term>
<term>Morphine (administration & dosage)</term>
<term>Morphine (adverse effects)</term>
<term>Morphine (contraindications)</term>
<term>Narcotics (administration & dosage)</term>
<term>Narcotics (adverse effects)</term>
<term>Narcotics (contraindications)</term>
<term>Oxymorphone (administration & dosage)</term>
<term>Oxymorphone (adverse effects)</term>
<term>Oxymorphone (contraindications)</term>
<term>Pseudarthrosis (drug therapy)</term>
<term>Retrospective Studies</term>
<term>Skin (pathology)</term>
<term>Venous Insufficiency (diagnosis)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Arachnoïdite (traitement médicamenteux)</term>
<term>Causalité</term>
<term>Comorbidité</term>
<term>Hyperpigmentation ()</term>
<term>Hyperpigmentation (diagnostic)</term>
<term>Hyperpigmentation (épidémiologie)</term>
<term>Incidence</term>
<term>Injections rachidiennes</term>
<term>Insuffisance veineuse (diagnostic)</term>
<term>Jambe (anatomopathologie)</term>
<term>Lymphoedème (diagnostic)</term>
<term>Maladie chronique</term>
<term>Morphine ()</term>
<term>Morphine (administration et posologie)</term>
<term>Morphine (effets indésirables)</term>
<term>Oedème ()</term>
<term>Oedème (diagnostic)</term>
<term>Oedème (épidémiologie)</term>
<term>Oxymorphone ()</term>
<term>Oxymorphone (administration et posologie)</term>
<term>Oxymorphone (effets indésirables)</term>
<term>Peau (anatomopathologie)</term>
<term>Pied (anatomopathologie)</term>
<term>Pompes à perfusion implantables</term>
<term>Pseudarthrose (traitement médicamenteux)</term>
<term>Stupéfiants ()</term>
<term>Stupéfiants (administration et posologie)</term>
<term>Stupéfiants (effets indésirables)</term>
<term>Études rétrospectives</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en">
<term>Morphine</term>
<term>Narcotics</term>
<term>Oxymorphone</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en">
<term>Morphine</term>
<term>Narcotics</term>
<term>Oxymorphone</term>
</keywords>
<keywords scheme="MESH" qualifier="administration et posologie" xml:lang="fr">
<term>Morphine</term>
<term>Oxymorphone</term>
<term>Stupéfiants</term>
</keywords>
<keywords scheme="MESH" qualifier="anatomopathologie" xml:lang="fr">
<term>Jambe</term>
<term>Peau</term>
<term>Pied</term>
</keywords>
<keywords scheme="MESH" qualifier="chemically induced" xml:lang="en">
<term>Edema</term>
<term>Hyperpigmentation</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="contraindications" xml:lang="en">
<term>Morphine</term>
<term>Narcotics</term>
<term>Oxymorphone</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnosis" xml:lang="en">
<term>Edema</term>
<term>Hyperpigmentation</term>
<term>Lymphedema</term>
<term>Venous Insufficiency</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnostic" xml:lang="fr">
<term>Hyperpigmentation</term>
<term>Insuffisance veineuse</term>
<term>Lymphoedème</term>
<term>Oedème</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en">
<term>Arachnoiditis</term>
<term>Pseudarthrosis</term>
</keywords>
<keywords scheme="MESH" qualifier="effets indésirables" xml:lang="fr">
<term>Morphine</term>
<term>Oxymorphone</term>
<term>Stupéfiants</term>
</keywords>
<keywords scheme="MESH" qualifier="epidemiology" xml:lang="en">
<term>Edema</term>
<term>Hyperpigmentation</term>
</keywords>
<keywords scheme="MESH" qualifier="pathology" xml:lang="en">
<term>Foot</term>
<term>Leg</term>
<term>Skin</term>
</keywords>
<keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr">
<term>Arachnoïdite</term>
<term>Pseudarthrose</term>
</keywords>
<keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr">
<term>Hyperpigmentation</term>
<term>Oedème</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Causality</term>
<term>Chronic Disease</term>
<term>Comorbidity</term>
<term>Incidence</term>
<term>Infusion Pumps, Implantable</term>
<term>Injections, Spinal</term>
<term>Retrospective Studies</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Causalité</term>
<term>Comorbidité</term>
<term>Hyperpigmentation</term>
<term>Incidence</term>
<term>Injections rachidiennes</term>
<term>Maladie chronique</term>
<term>Morphine</term>
<term>Oedème</term>
<term>Oxymorphone</term>
<term>Pompes à perfusion implantables</term>
<term>Stupéfiants</term>
<term>Études rétrospectives</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Despite the increasing popularity of intrathecal infusions to treat patients with long-term non-cancer-related pain, this therapy is not without serious side-effects. Five out of 23 patients who had intrathecal infusions of opiates for longer than 24 months developed leg and feet edema. As predisposing factors, cardiovascular disease, deep venous thrombosis, peripheral vascular disease, and venous stasis of the lower extremities were considered. Every patient who developed pedal and leg edema after the implantation of an infusion pump was also found to have leg edema and venous stasis prior to the time when the pump was inserted. This complication was severe enough to limit their physical activity, and to produce lymphedema, ulcerations and hyperpigmentation of the skin. Reduction of the edema occurred when the dose of the opiate was decreased, and in two cases in which the infusion was discontinued, there was almost complete resolution of the syndrome. It appears that the pre-existence of pedal edema and of venous stasis is a relative contraindication to the long-term intrathecal infusion of opiates in patients with chronic non-cancer pain.</div>
</front>
</TEI>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Ncbi/Curation

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000505 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd -nk 000505 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    LymphedemaV1
   |flux=    Ncbi
   |étape=   Curation
   |type=    RBID
   |clé=     pubmed:11124008
   |texte=   Leg edema from intrathecal opiate infusions.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/RBID.i   -Sk "pubmed:11124008" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd   \
       | NlmPubMed2Wicri -a LymphedemaV1
Wicri

This area was generated with Dilib version V0.6.31.
Data generation: Sat Nov 4 17:40:35 2017. Site generation: Tue Feb 13 16:42:16 2024